Skip to main content
Ocular InflammationDiagnostics and screeningDevicePhase 1

What this study is

The purpose of this study to find out whether a device that delivers mild electrical stimulation to the ear (transcutaneous auricular vagus nerve stimulation, or taVNS) can reduce inflammation in the eye in people with ocular inflammatory conditions. The device is called the Cymbathera One System.

What's being tested

  • Cymbathera One System

    Intervention · DEVICE

    Cymbathera One System provides transcutaneous electrical stimulation to the auricular branch of the vagus nerve

Study details

Official title
Assessment of Transcutaneous Auricular Vagus Nerve Stimulation for Ocular Inflammatory Conditions
Sponsor
Memorial Sloan Kettering Cancer Center
Conditions
Ocular Inflammation · Crystalline Lens; Chalcosis · Intraocular Lens Complication
Enrolling
20 people
Starts
2026-09-09
Est. completion
2028-09-09
Design
Open-label, non-randomized, parallel groups, Phase 1
Record
View on ClinicalTrials.gov ↗